46180dkk
-0,9 %
Date:2025-05-28Time:17:20:00Latest report:Q4-2023List:Large CapTicker:NSIS B
Market Cap:216 261 mdkkEnterprise Value:222 926 mdkkNet Sales:17 899 mdkkEarnings:3 024 mdkkEmployees:0ISIN:DK0060336014
Ratios
10-year key figure history for Novonesis turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Novonesis with index and moving average MA50 and MA200.
Stockprice:461,80
MA50:421,50
MA200:427,43
Price/MA200:8,0 %
RSI (14):67,9
Price/MA50:9,6 %
Description
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Chemicals
1 week
1 month
aXichem
4,2 %
100,0 %
Bioextrax
-4,2 %
21,6 %
I-Tech
2,6 %
20,2 %
SP Group
4,1 %
15,7 %
Clemondo
0,9 %
13,7 %
Roblon
3,6 %
13,2 %
Nexam Chemical
13,5 %
10,3 %
Yara International
-2,8 %
9,2 %
Nolato
5,7 %
9,1 %